← All organizations
Bambino Gesù Hospital and Research Institute
Academic/HospitalWebsite ↗
Also known as: Bambino Gesù Children's Hospital IRCCS Rome | Bambino Gesu Hospital | Bambino Gesù Hospital and Research Institute | Dept. of Pediatric Hematology Oncology - Bambino Gesù Children's Hospital Rome | Franco Locatelli | IRCCS, Ospedale Pediatrico Bambino Gesu | Mariella Enoc | Ospedale Pediatrico Bambino | Ospedale Pediatrico Bambino (co-sponsor, Italy) | Ospedale Pediatrico Bambino Gesu
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2003Last known activity
Jan 15, 2026
Timeline
1860s
- Jun 1, 1869
Bambino Gesù Hospital and Research Institute— Founded
Drugs by trial phase (58 distinct, 39 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (28 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- 22q11 Deletion Syndrome
- Acute Kidney Injury
- Atrophy
- Candidiasis
- Cardiac Output, Low
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Fatty Liver
- Fibrosis
- Genetic Diseases, Inborn
- Graft vs Host Disease
- Heart Failure
- HIV Infections
- Homocystinuria
- Inflammation
- Insulin Resistance
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Diseases
- Lymphoma, Non-Hodgkin
- Meningitis
- Metabolic Syndrome
- Muscular Atrophy
- Muscular Atrophy, Spinal
- Myelodysplastic Syndromes
- Neonatal Sepsis
- Nephrosis
- Nephrotic Syndrome
- Neuroblastoma
- Non-alcoholic Fatty Liver Disease
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Renal Insufficiency
- Sepsis
- Spinal Muscular Atrophies of Childhood
- Status Epilepticus
- Syndrome
- Transposition of Great Vessels
Recent trials (50)
- NCT07297914Lead sponsorPhase 2/Phase 3Jan 15, 2026
- NCT06080191Lead sponsorPhase 1Jan 31, 2024
- NCT06064903Lead sponsorPhase 1/Phase 2Jan 1, 2024
- NCT06465823Sponsor investigatorPhase 2Jan 11, 2023
- NCT06465823Lead sponsorPhase 2Jan 11, 2023
- NCT06465823OfficialPhase 2Jan 11, 2023
- NCT05298995Lead sponsorPhase 1May 31, 2022
- NCT05298995Reponsible party - principal investigatorPhase 1May 31, 2022
- NCT04966234Lead sponsorPhase 2/Phase 3Apr 22, 2021
- NCT04787263Lead sponsorPhase 1/Phase 2Mar 4, 2021
- NCT04964427Lead sponsorN/AFeb 8, 2021
- NCT04964427Reponsible party - principal investigatorN/AFeb 8, 2021
- NCT04646135Reponsible party - principal investigatorPhase 2Dec 31, 2020
- NCT04646135Overall official - principal investigatorPhase 2Dec 31, 2020
- NCT04646135Lead sponsorPhase 2Dec 31, 2020
Details
- Founded
- Rome, IT Jun 1, 1869
- Last known activity
- Jan 15, 2026